[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 55,654
Sort by:

Neisseria meningitidis Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Neisseria meningitidis Infections Drug pipeline report- 2020 is an annual R&D review of Neisseria meningitidis Infections pipeline candidates. The report presents the current status of all major Neiss...

October 2019 70 pages

Osteomyelitis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Osteomyelitis Drug pipeline report- 2020 is an annual R&D review of Osteomyelitis pipeline candidates. The report presents the current status of all major Osteomyelitis therapeutic compounds. Detailed...

October 2019 30 pages

Pertussis (Whooping Cough) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Pertussis (Whooping Cough) Drug pipeline report- 2020 is an annual R&D review of Pertussis (Whooping Cough) pipeline candidates. The report presents the current status of all major Pertussis (Whooping...

October 2019 70 pages

Poliomyelitis (Polio) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Poliomyelitis (Polio) Drug pipeline report- 2020 is an annual R&D review of Poliomyelitis (Polio) pipeline candidates. The report presents the current status of all major Poliomyelitis (Polio) therape...

October 2019 70 pages

Progressive Multifocal Leukoencephalopathy Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Progressive Multifocal Leukoencephalopathy Drug pipeline report- 2020 is an annual R&D review of Progressive Multifocal Leukoencephalopathy pipeline candidates. The report presents the current status...

October 2019 40 pages

Pseudomonas aeruginosa Pneumonia Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Pseudomonas aeruginosa Pneumonia Drug pipeline report- 2020 is an annual R&D review of Pseudomonas aeruginosa Pneumonia pipeline candidates. The report presents the current status of all major Pseudom...

October 2019 40 pages

Pyelonephritis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Pyelonephritis Drug pipeline report- 2020 is an annual R&D review of Pyelonephritis pipeline candidates. The report presents the current status of all major Pyelonephritis therapeutic compounds. Detai...

October 2019 60 pages

Q Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Q Fever Drug pipeline report- 2020 is an annual R&D review of Q Fever pipeline candidates. The report presents the current status of all major Q Fever therapeutic compounds. Detailed insights into Q F...

October 2019 20 pages

Rabies Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Rabies Drug pipeline report- 2020 is an annual R&D review of Rabies pipeline candidates. The report presents the current status of all major Rabies therapeutic compounds. Detailed insights into Rabies...

October 2019 60 pages

Rhinovirus Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Rhinovirus Infections Drug pipeline report- 2020 is an annual R&D review of Rhinovirus Infections pipeline candidates. The report presents the current status of all major Rhinovirus Infections therape...

October 2019 50 pages

Rotavirus Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Rotavirus Infections Drug pipeline report- 2020 is an annual R&D review of Rotavirus Infections pipeline candidates. The report presents the current status of all major Rotavirus Infections therapeuti...

October 2019 50 pages

Schistosomiasis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Schistosomiasis Drug pipeline report- 2020 is an annual R&D review of Schistosomiasis pipeline candidates. The report presents the current status of all major Schistosomiasis therapeutic compounds. De...

October 2019 40 pages

Severe Acute Respiratory Syndrome (SARS) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Severe Acute Respiratory Syndrome (SARS) Drug pipeline report- 2020 is an annual R&D review of Severe Acute Respiratory Syndrome (SARS) pipeline candidates. The report presents the current status of a...

October 2019 70 pages

Smallpox Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Smallpox Drug pipeline report- 2020 is an annual R&D review of Smallpox pipeline candidates. The report presents the current status of all major Smallpox therapeutic compounds. Detailed insights into...

October 2019 50 pages

Streptococcus pyogenes Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Streptococcus pyogenes Infections Drug pipeline report- 2020 is an annual R&D review of Streptococcus pyogenes Infections pipeline candidates. The report presents the current status of all major Strep...

October 2019 50 pages

Tetanus Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Tetanus Drug pipeline report- 2020 is an annual R&D review of Tetanus pipeline candidates. The report presents the current status of all major Tetanus therapeutic compounds. Detailed insights into Tet...

October 2019 70 pages

Tinea pedis (Athlete Foot) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Tinea pedis (Athlete Foot) Drug pipeline report- 2020 is an annual R&D review of Tinea pedis (Athlete Foot) pipeline candidates. The report presents the current status of all major Tinea pedis (Athlet...

October 2019 40 pages

Toxoplasmosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Toxoplasmosis Drug pipeline report- 2020 is an annual R&D review of Toxoplasmosis pipeline candidates. The report presents the current status of all major Toxoplasmosis therapeutic compounds. Detailed...

October 2019 40 pages

Tularemia Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Tularemia Drug pipeline report- 2020 is an annual R&D review of Tularemia pipeline candidates. The report presents the current status of all major Tularemia therapeutic compounds. Detailed insights in...

October 2019 40 pages

Typhoid Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Typhoid Fever Drug pipeline report- 2020 is an annual R&D review of Typhoid Fever pipeline candidates. The report presents the current status of all major Typhoid Fever therapeutic compounds. Detailed...

October 2019 50 pages

Vancomycin Resistant Enterococcus (VRE) faecium Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Vancomycin Resistant Enterococcus (VRE) faecium Infections Drug pipeline report- 2020 is an annual R&D review of Vancomycin Resistant Enterococcus (VRE) faecium Infections pipeline candidates. The rep...

October 2019 70 pages

Vancomycin Resistant Staphylococcus aureus (VRSA) Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Vancomycin Resistant Staphylococcus aureus (VRSA) Infections Drug pipeline report- 2020 is an annual R&D review of Vancomycin Resistant Staphylococcus aureus (VRSA) Infections pipeline candidates. The...

October 2019 50 pages

Ventilator Associated Pneumonia (VAP) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Ventilator Associated Pneumonia (VAP) Drug pipeline report- 2020 is an annual R&D review of Ventilator Associated Pneumonia (VAP) pipeline candidates. The report presents the current status of all maj...

October 2019 80 pages

West Nile Virus Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

West Nile Virus Infections Drug pipeline report- 2020 is an annual R&D review of West Nile Virus Infections pipeline candidates. The report presents the current status of all major West Nile Virus Inf...

October 2019 50 pages

Western Equine Encephalitis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Western Equine Encephalitis Drug pipeline report- 2020 is an annual R&D review of Western Equine Encephalitis pipeline candidates. The report presents the current status of all major Western Equine En...

October 2019 40 pages

Yellow Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Yellow Fever Drug pipeline report- 2020 is an annual R&D review of Yellow Fever pipeline candidates. The report presents the current status of all major Yellow Fever therapeutic compounds. Detailed in...

October 2019 60 pages

Global Acromegaly Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... structured to provide clear and actionable insights into Acromegaly drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Acromegaly Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 78 pages

Global Actinic (Solar) Keratosis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... 2 Actinic (Solar) Keratosis drugs Late phase: Phase 3 and in-approval Actinic (Solar) Keratosis drugs Companies involved in the Pipeline- Company overview Snapshot Actinic (Solar) Keratosis therapeutic treatment activities Details for each Actinic (Solar) Keratosis drug ...

August 2019 62 pages

Global Alcohol Addiction Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... causes of Alcohol Addiction condition and increased access to investments is encouraging growth of Alcohol Addiction drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Alcohol Addiction drug pipeline for companies to optimize spending levels by understanding ...

August 2019 132 pages

Global Anesthetic Effect Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... causes of Anesthetic Effect condition and increased access to investments is encouraging growth of Anesthetic Effect drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Anesthetic Effect drug pipeline for companies to optimize spending levels by understanding ...

August 2019 81 pages

Global Angina (Angina Pectoris) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... 2 Angina (Angina Pectoris) drugs Late phase: Phase 3 and in-approval Angina (Angina Pectoris) drugs Companies involved in the Pipeline- Company overview Snapshot Angina (Angina Pectoris) therapeutic treatment activities Details for each Angina (Angina Pectoris) drug ...

August 2019 57 pages

Global Arrhythmias Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... structured to provide clear and actionable insights into Arrhythmias drug pipeline for companies to optimize spending levels by understanding competition, ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Arrhythmias Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 60 pages

Global Arterial Thrombosis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... of Arterial Thrombosis condition and increased access to investments is encouraging growth of Arterial Thrombosis drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Arterial Thrombosis drug pipeline for companies to optimize spending levels by understanding ...

August 2019 49 pages

Global Atrial Fibrillation Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... of Atrial Fibrillation condition and increased access to investments is encouraging growth of Atrial Fibrillation drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Atrial Fibrillation drug pipeline for companies to optimize spending levels by understanding ...

August 2019 93 pages

Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... in-approval Attention Deficit Hyperactivity Disorder (ADHD) drugs Companies involved in the Pipeline- Company overview Snapshot Attention Deficit Hyperactivity Disorder (ADHD) therapeutic treatment activities Details for each Attention Deficit Hyperactivity Disorder (ADHD ...

August 2019 142 pages

Global Autism Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... is structured to provide clear and actionable insights into Autism drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Autism Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 145 pages

Global Axillary Hyperhidrosis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... Axillary Hyperhidrosis condition and increased access to investments is encouraging growth of Axillary Hyperhidrosis drug pipeline. However, despite high levels of pipeline activity ... provide clear and actionable insights into Axillary Hyperhidrosis drug pipeline for companies to optimize spending levels by ...

August 2019 45 pages

Global Batten Disease Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... causes of Batten Disease condition and increased access to investments is encouraging growth of Batten Disease drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Batten Disease drug pipeline for companies to optimize spending levels by understanding ...

August 2019 59 pages

Global Behcet Disease Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... causes of Behcet Disease condition and increased access to investments is encouraging growth of Behcet Disease drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Behcet Disease drug pipeline for companies to optimize spending levels by understanding ...

August 2019 47 pages

Global Binge Eating Disorder Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... 2 Binge Eating Disorder drugs Late phase: Phase 3 and in-approval Binge Eating Disorder drugs Companies involved in the Pipeline- Company overview Snapshot Binge Eating Disorder therapeutic treatment activities Details for each Binge Eating Disorder drug ...

August 2019 52 pages

Global Bullous Pemphigoid Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... of Bullous Pemphigoid condition and increased access to investments is encouraging growth of Bullous Pemphigoid drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Bullous Pemphigoid drug pipeline for companies to optimize spending levels by understanding ...

August 2019 50 pages

Global Burns Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... is structured to provide clear and actionable insights into Burns drug pipeline for companies to optimize spending levels by understanding competition, their ... quality checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Burns Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 109 pages

Global Canavan Disease Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... causes of Canavan Disease condition and increased access to investments is encouraging growth of Canavan Disease drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Canavan Disease drug pipeline for companies to optimize spending levels by understanding ...

August 2019 35 pages

Global Cancer related Pain Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... 2 Cancer related Pain drugs Late phase: Phase 3 and in-approval Cancer related Pain drugs Companies involved in the Pipeline- Company overview Snapshot Cancer related Pain therapeutic treatment activities Details for each Cancer related Pain drug ...

August 2019 125 pages

Global Cerebral Palsy Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... causes of Cerebral Palsy condition and increased access to investments is encouraging growth of Cerebral Palsy drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Cerebral Palsy drug pipeline for companies to optimize spending levels by understanding ...

August 2019 40 pages

Global Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... in-approval Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) drugs Companies involved in the Pipeline- Company overview Snapshot Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) therapeutic treatment activities Details for each Chronic Inflammatory Demyelinating Polyneuropathy (CIDP ...

August 2019 52 pages

Global Chronic Traumatic Encephalopathy Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... 2 Chronic Traumatic Encephalopathy drugs Late phase: Phase 3 and in-approval Chronic Traumatic Encephalopathy drugs Companies involved in the Pipeline- Company overview Snapshot Chronic Traumatic Encephalopathy therapeutic treatment activities Details for each Chronic Traumatic Encephalopathy drug ...

August 2019 45 pages

Global Chronic Urticaria Or Hives Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... 3 and in-approval Chronic Urticaria Or Hives drugs Companies involved in the Pipeline- Company overview Snapshot Chronic Urticaria Or Hives therapeutic treatment activities Details for each Chronic Urticaria Or Hives drug candidate ...

August 2019 65 pages

Global Cluster Headache Syndrome Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... 2 Cluster Headache Syndrome drugs Late phase: Phase 3 and in-approval Cluster Headache Syndrome drugs Companies involved in the Pipeline- Company overview Snapshot Cluster Headache Syndrome therapeutic treatment activities Details for each Cluster Headache Syndrome drug ...

August 2019 45 pages

Global Cognitive Impairment Associated With Schizophrenia (CIAS) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... Cognitive Impairment Associated With Schizophrenia (CIAS) drugs Companies involved in the Pipeline- Company overview Snapshot Cognitive Impairment Associated With Schizophrenia (CIAS) therapeutic treatment activities Details for each Cognitive Impairment Associated With ...

August 2019 79 pages

Filters

Search

Categories

12,968
1,223
4,429
2
1
8,271
2,818
15,138
67
8,921
1
1,229
586

Publishers

55,654

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
55,617

Price

Date

Pages

Offers